Article Details
Retrieved on: 2018-12-25 07:37:21
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Finally, <b>Sofinnova Ventures</b> Inc bought a new stake in Entasis Therapeutics in the third quarter valued at approximately $12,840,000. 66.61% of the ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here